Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIT-dose Study: Low-dose prednisolone after steroid pulse for acute exacerbation of idiopathic interstitial pneumonia
jRCT1061220085Active, not recruiting
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in idiopathic interstitial pneumonia (IIP). Primary endpoint: Treatment success rate at day 18. Started Aug 2023; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
idiopathic interstitial pneumonia (IIP)
Beyond the preview
Go deeper on jRCT1061220085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061220085.